# A Study of AND017 in Cancer Related Anemic Patients Receiving Chemotherapy

> **NCT06075030** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Kind Pharmaceuticals LLC** · enrollment: 36 (estimated)

## Conditions studied

- Chemotherapy Induced Anemia

## Interventions

- **DRUG:** AND017

## Key facts

- **NCT ID:** NCT06075030
- **Lead sponsor:** Kind Pharmaceuticals LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2027-12
- **Primary completion:** 2027-12
- **Final completion:** 2028-05
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2026-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06075030

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06075030, "A Study of AND017 in Cancer Related Anemic Patients Receiving Chemotherapy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06075030. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*